Location of Repository

Association of the 894G>T polymorphism in the endothelial nitric oxide synthase gene with risk of acute myocardial infarction

By George K. Andrikopoulos, Dimitris Grammatopoulos, Stylianos E. Tzeis, Sevasti I. Zervou, Dimitris J. Richter, Michalis N. Zairis, Elias J. Gialafos, Dimitris C. Sakellariou, Stefanos G. Foussas, Antonis S. Manolis, Christodoulos I. Stefanadis, Pavlos K. Toutouzas and Edward W. Hillhouse

Abstract

Background: This study was designed to investigate the association of the 894G>T polymorphism in the eNOS gene with risk of acute myocardial infarction (AMI), extent of coronary artery disease (CAD) on coronary angiography, and in-hospital mortality after AMI.\ud Methods: We studied 1602 consecutive patients who were enrolled in the GEMIG study. The control group was comprised by 727 individuals, who were randomly selected from the general adult population.\ud Results: The prevalence of the Asp298 variant of eNOS was not found to be significantly and independently associated with risk of AMI (RR = 1.08, 95%CI = 0.77–1.51, P = 0.663), extent of CAD on angiography (OR = 1.18, 95%CI = 0.63–2.23, P = 0.605) and in-hospital mortality (RR = 1.08, 95%CI = 0.29–4.04, P = 0.908).\ud Conclusion: In contrast to previous reports, homozygosity for the Asp298 variant of the 894G>T polymorphism in the eNOS gene was not found to be associated with risk of AMI, extent of CAD and in-hospital mortality after AM

Topics: RC
Publisher: BioMed Central Ltd.
Year: 2008
OAI identifier: oai:wrap.warwick.ac.uk:530

Suggested articles

Preview

Citations

  1. (2005). A: The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thromb Res doi
  2. (2003). AM, London B: Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure. Circulation doi
  3. (1999). Benessiano J: G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation doi
  4. (2004). Channon KM: Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics doi
  5. (2001). Chimonas ET: In-hospital mortality of habitual cigarette smokers after acute myocardial infarction. The smoker's paradox in a countrywide study. Eur Heart J
  6. (2004). Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23 028 subjects. Circulation doi
  7. (2003). Functional characterization of Glu298Asp mutant human endothelial nitric oxide synthase purified from a yeast expression system. Nitric Oxide doi
  8. (2004). GEMIG Study Investigators: Association of the ile405val mutation in cholesteryl ester transfer protein gene with risk of acute myocardial infarction. Heart
  9. (2005). GEMIG study investigators: Lack of association between common polymorphisms in genes of the renin-angiotensin system and mortality after myocardial infarction. Cardiology doi
  10. (2004). GEMIG study investigators: The paradoxical association of common polymorphisms of the renin-angiotensin system genes with risk of myocardial infarction. Eur J Cardiovasc Prev Rehabil doi
  11. (2005). Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction. doi
  12. (2000). Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett doi
  13. (2002). Haberbosch W: The T allele of the missense Glu(298)Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile. Atherosclerosis doi
  14. (2006). Hu FB: Common variants of the endothelial nitric oxide synthase gene and the risk of coronary heart disease among U.S. diabetic men. Diabetes doi
  15. (2006). Ignarro LJ: Nitric oxide and atherosclerosis: An update. Nitric Oxide in press. doi
  16. (2000). Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci doi
  17. (2003). Kastrati A: Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement. doi
  18. (2003). KB: The Glu298Asp polymorphism in the endothelial nitric oxide synthase gene is strongly associated with coronary spasm. Coron Artery Dis doi
  19. (1993). KT: Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase.
  20. (2001). Mamotte CD: Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J Cardiovasc Risk doi
  21. (2004). MG: Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298-->Asp and T-786-->C polymorphisms. Stroke doi
  22. (1999). MJ: A common variant of the endothelial nitric oxide synthase (Glu298->Asp) is a major risk factor for coronary artery disease in the UK. Circulation doi
  23. (2006). Moibenko AA: Allelic polymorphism of endothelial NO-synthase gene and its functional manifestations. Acta Biochim Pol
  24. (2001). Muller-Esterl W: NOSIP, a novel modulator of endothelial nitric oxide synthase activity. doi
  25. (2001). Pompeo FVecchione C, Trimarco B: A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke doi
  26. (2004). PP: Endothelial nitric oxide synthase gene polymorphism and ischemic heart disease. Am Heart J doi
  27. (2002). Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. doi
  28. (2004). Richter DJ: Genetic factors in exceptional longevity. JAMA
  29. (2001). Risk stratification of coronary heart disease through established and emerging lifestyle factors in a Mediterranean population: CARDIO2000 epidemiological study. doi
  30. (2003). Shuldiner AR: Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA
  31. (2002). The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis. Eur Heart J doi
  32. (2002). The Glu298Asp polymorphism of the NOS3 gene as a determinant of the baseline production of nitric oxide. doi
  33. (2001). WC: Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)3Asp variant of human endothelial nitric-oxide synthase. doi
  34. (1997). WC: Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.